HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 21, No 03, March 2017 – Get to Know TCM       » Chinese Scientists in Rice Breakthrough       » Leading Regional Medical Technology Trade Associations Reinforce their Commitment to Evidence-based Healthcare       » New Study Finds Extensive Use of Fluorinated Chemicals in Fast Food Wrap       » What Doesn't Kill You Makes You Stronger       » Life Under Pressure       » Understanding the Genetics of Human Height      
INSIDE INDUSTRY
Tim Reiner joins Mundipharmas regional office

Tim Reiner has been appointed as Mundipharma's Head of Business Development for Asia, Latin America and the Middle East/North Africa with effect from 1 June, 2013, to further strengthen the company's presence in key growth regions.

Tim joins Mundipharma Pte. Ltd. from McKinsey where he spent the last 7 years on the McKinsey Global Rotation Program, leading more than 55 consulting projects across pharmaceutical, consumer, and other healthcare and industrial clients. Since 2010, he was one of the leaders in McKinsey's EMEA Pharmaceutical and Medical Products Practice, and co-founded the Healthcare/Private Equity practice joint-venture.

During his tenure, in addition to his client service, he led the development of McKinsey's standard approach for pharmaceutical and medical product diligences, and served as faculty at McKinsey's internal private equity and due diligence trainings. Prior to McKinsey, Tim worked with a mid-market private equity fund and the University of Minnesota's Ventures Enterprise to identify investment opportunities in biopharmaceuticals and other industries.

Raman Singh, Regional Director, Asia Pacific, Latin America, Middle East and Africa, said, “We are delighted to have Tim on board with Mundipharma in Singapore, bringing his rich experience and proven leadership abilities in pharmaceutical and medical products practices across multiple important markets globally. Having him head our business development in Asia, Latin American, and the Middle East/North Africa will bring positive growth and help Mundipharma further strengthen our operations throughout these developing regions.”

Tim Reiner, who relocated to Singapore in June, said, “I’m excited to be joining Mundipharma, a company with such wide reach globally, and that has been delivering consistently high quality products in the field of pain management. It's great to be part of a company still very open to exploring new fields and dedicated to expanding its business for patients worldwide.”

Click here for the complete issue.

NEWS CRUNCH  
news Philip Morris International and British American Tobacco receive award from PETA science group for AOP developments
news 6th Asia-Pacific Breast Cancer Summit to take place in Hong Kong
news MIT Hacking Medicine Robotics in Singapore!
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Healthcare Focus: LUNGS
February:
War on CANCER
March:
Get to Know TCM
April:
Diabetics Technology
May:
The Piece of Your Mind - Brain Health/Science
June:
Women & Men's Health
July:
Food Science & Technology
August:
Eye Care/ Eye Health
September:
No. 1 Killer - Heart Diseases, Diagnosis and Treatment
October:
Skin Diseases/Allergic Reactions
November:
Diseases threatening our Children
December:
Liver Health & Treatment/Technology
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy